ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,972,533 | -45.9% | 106,124 | -39.6% | 0.00% | -50.0% |
| Q2 2023 | $5,496,030 | +97.7% | 175,592 | +78.1% | 0.00% | +100.0% |
| Q1 2023 | $2,779,900 | +177.9% | 98,613 | +157.6% | 0.00% | – |
| Q4 2022 | $1,000,413 | -59.0% | 38,286 | -53.3% | 0.00% | -100.0% |
| Q2 2022 | $2,441,000 | +4.9% | 81,932 | -7.3% | 0.00% | – |
| Q1 2022 | $2,327,000 | -23.7% | 88,427 | -32.5% | 0.00% | -100.0% |
| Q4 2021 | $3,049,000 | -5.1% | 131,100 | +25.8% | 0.00% | 0.0% |
| Q3 2021 | $3,214,000 | +55.6% | 104,200 | +23.7% | 0.00% | – |
| Q2 2021 | $2,065,000 | +709.8% | 84,238 | +517.3% | 0.00% | – |
| Q1 2021 | $255,000 | -75.0% | 13,647 | -73.3% | 0.00% | -100.0% |
| Q4 2020 | $1,020,000 | +20.6% | 51,150 | +0.1% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | +88.4% | 51,090 | +120.8% | 0.00% | – |
| Q2 2020 | $449,000 | -71.8% | 23,134 | -79.0% | 0.00% | -100.0% |
| Q1 2020 | $1,590,000 | -29.1% | 110,280 | +0.3% | 0.00% | -66.7% |
| Q4 2019 | $2,243,000 | +573.6% | 109,921 | +545.0% | 0.00% | +200.0% |
| Q3 2019 | $333,000 | -33.4% | 17,042 | +0.7% | 0.00% | 0.0% |
| Q4 2018 | $500,000 | -75.9% | 16,924 | -65.3% | 0.00% | -75.0% |
| Q3 2018 | $2,073,000 | +220.9% | 48,842 | +338.3% | 0.00% | +100.0% |
| Q1 2018 | $646,000 | +94.6% | 11,144 | +94.7% | 0.00% | +100.0% |
| Q2 2017 | $332,000 | -56.4% | 5,723 | -56.1% | 0.00% | -66.7% |
| Q1 2017 | $762,000 | +2.7% | 13,031 | -39.9% | 0.00% | -25.0% |
| Q1 2016 | $742,000 | -84.4% | 21,700 | -63.7% | 0.00% | -86.7% |
| Q4 2015 | $4,747,000 | +811.1% | 59,803 | +574.0% | 0.03% | +900.0% |
| Q3 2015 | $521,000 | +67.0% | 8,873 | +82.9% | 0.00% | +50.0% |
| Q2 2015 | $312,000 | -77.2% | 4,852 | -78.4% | 0.00% | -81.8% |
| Q1 2015 | $1,368,000 | -39.2% | 22,437 | -49.8% | 0.01% | -62.1% |
| Q2 2014 | $2,251,000 | +394.7% | 44,715 | +333.0% | 0.03% | +480.0% |
| Q1 2014 | $455,000 | – | 10,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |